Local facial cutaneous vasoconstriction: an unusual complication of inhaled racemic epinephrine in a neonate

J Perinatol. 2013 Dec;33(12):985-6. doi: 10.1038/jp.2013.115.

Abstract

A term infant treated for post-extubation stridor with nebulized racemic epinephrine developed localized facial blanching due to cutaneous absorption of the aerosolized vasoconstrictor. Local application of heat restored circulation to the afflicted area. This complication of a commonly used medication is not previously reported in the medical literature and has the potential for severe sequelae.

Publication types

  • Case Reports

MeSH terms

  • Administration, Inhalation
  • Face / blood supply*
  • Humans
  • Infant, Newborn
  • Male
  • Racepinephrine / adverse effects*
  • Vasoconstriction*
  • Vasoconstrictor Agents / adverse effects*

Substances

  • Vasoconstrictor Agents
  • Racepinephrine